Vera Therapeutics Q1 2026 Earnings EPS Miss Highlights PreRevenue Stage Challenges Energy Focus Q4 2024 Earnings Narrowed Loss Reflects Ongoing Cost Controls Strategy Inc MSTR Q1 2026 Earnings Massive EPS Miss as Digital Asset Impairments Deepen Losses BLBD Q1 2026 Earnings EPS Surpasses Estimates by Nearly 11 Amid Positive Market Response NexGel Inc NXGL Q1 2026 Earnings EPS Miss on Higher Operating Costs